RAC 2.92% $1.94 race oncology ltd

Oncology - Pharma Deals News, page-157

  1. 130 Posts.
    lightbulb Created with Sketch. 57
    If RACE succeeds it's great for us shareholders but even better for the generations of lives that could be saved. It's a shame a great drug like Bisantrene wasn't out on the market after it's first stint of trials in the 80s...
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.